GlassScriptPhysician profile
Sarah Stacey
NPI 1053795781
$1,095.01
in general payments reported to CMS, 2019-2025
9 companies · $534 in 2025
The $534 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.51 · 2022: $23.71 · 2023: $124 · 2024: $388 · 2025: $534.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,047.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,046.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $356.14 | 2024-2025 | Fasenra, Tezspire, Breztri |
| Genzyme Corporation | $247.30 | 2023-2024 | |
| Glaxosmithkline, LLC. | $149.22 | 2024-2025 | Arexvy, Nucala |
| Spr Therapeutics, INC | $136.62 | 2025 | Sprint Pns System |
| Actelion Pharmaceuticals US, INC. | $118.43 | 2025 | Opsumit, Uptravi |
| Abbott Laboratories | $24.51 | 2021 | |
| Revance Therapeutics, INC. | $23.77 | 2024 | Daxxify |
| Abbvie INC. | $23.71 | 2022 | |
| Galderma Laboratories, L.P. | $15.31 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Stacey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.